MCK - McKesson Corporation
NEXT EARNINGS:
May 14, 2026
EPS Est: $11.36
|
Rev Est: $101.4B
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$967.33
DETAILS
HIGH:
$1050.00
LOW:
$900.00
MEDIAN:
$967.00
CONSENSUS:
$967.33
UPSIDE:
1.04%
Market Cap:
118.16B
Volume:
329,088
Avg Volume:
745,193
52 Week Range:
598.58-971.93
Sector:
Healthcare
Industry:
Medical - Distribution
Beta:
0.41
Last Dividend:
$3.28
Exchange:
NYSE
Country:
US
Employees:
44,000
IPO Date:
1994-11-10
EPS (TTM):
25.86
P/E Ratio:
26.02
Revenue (TTM):
359.05B
Total Assets:
75.14B
Total Debt:
7.39B
Cash & Equiv:
5.69B
Rev Growth (5Y):
9.2%
EPS Growth (5Y):
39.1%
FCF Growth (5Y):
6.2%
ROCE:
34.1%
Debt/Equity:
-3.56
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2026-02-04 | $9.34 | $9.17 | +1.9% | $106.2B | $105.8B | +0.3% |
| 2025-11-05 | $9.86 | $9.03 | +9.2% | $103.2B | $104.1B | -0.9% |
| 2025-08-06 | $8.26 | $8.14 | +1.5% | $97.8B | $96.2B | +1.7% |
| 2025-05-08 | $10.12 | $9.83 | +3.0% | $90.8B | $94.3B | -3.7% |
| 2025-02-05 | $8.03 | $8.60 | -6.6% | $95.3B | $96.1B | -0.8% |
| 2024-11-06 | $7.07 | $6.88 | +2.8% | $93.7B | $89.3B | +4.8% |
| 2024-08-07 | $7.88 | $7.21 | +9.3% | $79.3B | $82.5B | -3.9% |
| 2024-05-07 | $6.18 | $6.34 | -2.5% | $76.4B | $79.3B | -3.7% |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 359.05B | 308.95B | 276.71B | 263.97B | 238.23B | 231.05B | 214.32B | 208.36B | 198.53B | 190.88B | 179.04B | 137.61B |
| Net Income | 3.29B | 3.00B | 3.56B | 1.11B | (4.54B) | 900.00M | 34.00M | 67.00M | 5.18B | 2.26B | 1.48B | 1.26B |
| EPS | 25.86 | 22.54 | 25.23 | 7.31 | -27.02 | 4.97 | 0.17 | 0.32 | 22.95 | 9.82 | 6.37 | 5.51 |
| Total Assets | 75.14B | 67.44B | 62.32B | 63.30B | 65.02B | 61.25B | 59.67B | 60.38B | 60.97B | 56.56B | 53.87B | 51.76B |
| Total Debt | 7.39B | 7.39B | 7.29B | 7.54B | 9.40B | 9.40B | 7.59B | 7.88B | 8.54B | 8.15B | 9.84B | 10.72B |
| Cash & Equivalents | 5.69B | 4.58B | 4.68B | 3.53B | 6.28B | 4.01B | 2.98B | 2.67B | 2.78B | 4.05B | 5.34B | 4.19B |
| Operating Cash Flow | 6.08B | 4.31B | 5.16B | 4.43B | 4.54B | 4.37B | 4.04B | 4.34B | 4.74B | 3.67B | 3.11B | 3.14B |
| Free Cash Flow | 5.23B | 3.63B | 4.60B | 3.90B | 3.90B | 3.87B | 3.48B | 3.77B | 4.18B | 3.00B | 2.57B | 2.72B |
| FCF per Share | 41.02 | 27.23 | 32.61 | 25.60 | 24.29 | 21.37 | 17.72 | 18.10 | 18.92 | 13.02 | 11.06 | 11.88 |
| Book Value | (2.07B) | (1.97B) | (1.86B) | (2.27B) | (21.00M) | 5.09B | 8.09B | 9.80B | 11.10B | 8.92B | 8.00B | 8.52B |
| Cash & ST Investments | 5.69B | 4.58B | 4.68B | 3.53B | 6.28B | 4.01B | 2.98B | 2.67B | 2.78B | 4.05B | 5.34B | 4.19B |
| ROC Equity | N/A | N/A | N/A | N/A | N/A | 0.18 | 0.00 | 0.01 | 0.47 | 0.25 | 0.18 | 0.15 |